Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook




 

Hope for new prostate cancer test

17 May 2009

By Lorna Stewart

Appeared in BioNews 508

Screening the genetic material present in patients' urine could distinguish between aggressive from dormant prostate cancers, suggests a study published this month in the British Journal of Cancer. The research paper reports pilot findings from 11 prostate cancer patients and may provide new hope for the 34,000 men who are diagnosed with the disease each year. Differentiating between aggressive and dormant forms of prostate cancer is important since treatment is invasive and can leave men with long-term side effects, including incontinence and impotence. Conversely, dormant forms can be left untreated as they often do not progress.

The main method for distinguishing aggressive tumours currently is based upon detecting levels of protein in the urine. However, this method leads to false positives (classifying aggressive cancer as present when it is not) because other prostate conditions can cause excretion of the same proteins.

The new approach, led by Dr Jonas Nilsson from Umea University, Sweden, takes a step further back along the process and looks at the RNA which produces these proteins in the first place. RNA is the molecule responsible for 'reading' the DNA code  that makes up a gene, enabling the cell to make whichever proteins have been copied into RNA. The team showed that aggressive and dormant cancers showed differing RNA patterns, reflecting different gene activity. The results from this pilot study suggest that genetic information inside fatty deposits excreted in urine can be used for tumour detection and discovery of biomarkers of prostate cancer.

Dr Lesley Walker, director of cancer information at Cancer Research UK, said, 'This technique is a fresh view on an old problem and could really help scientists find that elusive biomarker. It's still unclear what the best treatment approach is for early prostate cancer, so it's important we find answers to this as soon as possible. Distinguishing the aggressive tumours that must be treated from those that don't need treatment will go a long way towards resolving this issue'.

SOURCES & REFERENCES
Cancer Research UK | 13 May 2009
 
BBC News Online | 13 May 2009
 
NHS Choices | 13 May 2009
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

22 August 2011 - by Sarah Pritchard 
US researchers have made a discovery that might help doctors distinguish between benign and more aggressive forms of prostate cancer. The team reports that a difference in the genetic make-up of prostate tumours could indicate which are likely to metastasize and spread through the body, and which will be slow-growing and non-fatal...
14 February 2011 - by Victoria Kay 
A genetic screening test could help doctors to identify men with the most aggressive types of prostate cancer, UK scientists believe. The test could save men with milder forms of the disease from unnecessary surgery and its potentially serious side effects...
06 December 2010 - by Julianna Photopoulos 
A protein that regulates prostate stem cell self-renewal and maintenance has been identified by US researchers. The so-called Bmi-1 protein also plays a role in the transformation of healthy prostate cells into cancerous ones...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust
Advertise your products and services HERE - click for further details

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation